Bionano Genomics Inc (NASDAQ:BNGO)

2.13
Delayed Data
As of Dec 07
 -0.04 / -1.85%
Today’s Change
1.16
Today|||52-Week Range
4.35
-28.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$620.6M

Company Description

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Contact Information

Bionano Genomics, Inc.
9540 Towne Centre Drive
San Diego California 92121
P:(858) 888-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders3.44%
Mutual fund holders15.25%
Other institutional12.46%

Top Executives

Robert Erik HolmlinPresident, CEO, Secretary & Director
Mark OldakowskiChief Operating Officer
Christopher StewartChief Financial & Accounting Officer
Alka ChaubeyChief Medical Officer
Jason PriarChief Commercial Officer